SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?


To: Scripts who wrote (1148)12/22/2000 1:09:13 PM
From: Ian@SI  Respond to of 1321
 
Ed,

With what's happened to QLT and the markets in general this year, who isn't concerned? <g>

Nevertheless, the fundamental story for QLT remains intact. It's the only treatment in town for a disease which would otherwise lead to blindness in half the people over age 50.

If you need the money within 6 months, it should never have been in the market, let alone an emerging biotech. I still believe that QLT will take out its old high by a very wide margin in less than 2 years.

The only time I'm concerned about a company's stock price is when I want to sell. At other times, it's merely a fleeting statistic.

Ian